Sexual dimorphism: The aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67, Issue 12, 2012, Pages 1365-1372

  Baylis, Chris ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Androgen; Asymmetric dimethylarginine; Cardiovascular events; Estrogen

Indexed keywords

ANDROGEN; ANGIOTENSIN II; NITRIC OXIDE;

AGED; AGING; ANIMAL; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; MALE; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW; SEXUAL DEVELOPMENT;

AGED; AGING; ANDROGENS; ANGIOTENSIN II; ANIMALS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY GLOMERULUS; MALE; NITRIC OXIDE; OXIDATIVE STRESS; SEX CHARACTERISTICS;

EID: 84869437650     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls171     Document Type: Article

References (107)

1. Levi M, Rowe JW. Renal function and dysfunction in aging. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. New York: Raven Press; 1992:3433-3456.
2. Baylis C, Corman B. The aging kidney: insights from experimental studies. J Am Soc Nephrol. 1998;9:699-709. (Pubitemid 28186060)
3. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int. 2000;57:2072-2079. (Pubitemid 30252299)
4. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69:2155-2161. (Pubitemid 43882101)
5. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987;31:1153-1159. (Pubitemid 17069099)
6. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159-166. (Pubitemid 46094690)
7. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare benefciaries. J Am Soc Nephrol. 2007;18:1299-1306. (Pubitemid 46536916)
8. Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl. 2005;97:S68-S77.
9. Wesson LG Jr. Renal hemodynamics in physiological states. In: Physiology of the human kidney. New York: Grune and Stratton; 1969:96-108.
10. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278-285. (Pubitemid 15087125)
11. Berg UB. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant. 2006;21:2577-2582. (Pubitemid 44644534)
12. Neugarten J, Gallo G, Silbiger S, Kasiske B. Glomerulosclerosis in aging humans is not infuenced by gender. Am J Kidney Dis. 1999;34:884-888. (Pubitemid 29521705)
13. Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE. Human nephron number: implications for health and disease. Pediatr Nephrol. 2011;26:1529-1533.
14. Ichikawa T, Fukuda M, Wakamatsu-Yamanaka T, et al. Low birth weight and end-stage renal disease: demographic analysis by region in Japan. Clin Exp Nephrol. 2012. Epub ahead of print.
15. Ritz E, Amann K, Koleganova N, Benz K. Prenatal programming-effects on blood pressure and renal function. Nat Rev Nephrol. 2011;7:137-144.
16. Munger K, Baylis C. Sex differences in renal hemodynamics in rats. Am J Physiol. 1988;254(2 Pt 2):F223-F231.
17. Hoppe CC, Evans RG, Bertram JF, Moritz KM. Effects of dietary protein restriction on nephron number in the mouse. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1768-R1774. (Pubitemid 46708530)
18. Neugarten J, Kasiske B, Silbiger SR, Nyengaard Jr. Effects of sex on renal structure. Nephron. 2002;90:139-144. (Pubitemid 34701987)
19. Remuzzi A, Puntorieri S, Mazzoleni A, Remuzzi G. Sex related differences in glomerular ultrafltration and proteinuria in Munich-Wistar rats. Kidney Int. 1988;34:481-486.
20. Remuzzi A, Puntorieri S, Alfano M, et al. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest. 1992;67:572-579.
21. Brenner BM, Lawler E V, Mackenzie HS. The hyperfltration theory: a paradigm shift in nephrology. Kidney Int. 1996;49:1774-1777. (Pubitemid 26186610)
22. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest. 1994;94:1823-1829.
23. Anderson S, Rennke HG, Zatz R. Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am J Physiol. 1994;267(1 Pt 2):F35-F43.
24. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int. 1997;51:1196-1204. (Pubitemid 27186546)
25. Schmieder RE, Schächinger H, Messerli FH. Accelerated decline in renal perfusion with aging in essential hypertension. Hypertension. 1994;23:351-357. (Pubitemid 24076719)
26. Fujihara CK, Limongi DMZP, DeOliveira HCF, Zatz R. Absence of focal glomerulosclerosis in aging analbuminemic rats. Am J Physiol. 1992;262:R947-R954.
27. Inoue T, Kozawa E, Okada H, et al. Noninvasive evaluation of kidney hypoxia and fbrosis using magnetic resonance imaging. J Am Soc Nephrol. 2011;22:1429-1434.
28. Kielstein JT, Bode-Böger SM, Frölich JC, Ritz E, Haller H, Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation. 2003;107:1891-1895. (Pubitemid 36444130)
29. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3:7.
30. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11:319-329. (Pubitemid 30064855)
31. Wells CC, Riazi S, Mankhey RW, Bhatti F, Ecelbarger C, Maric C. Diabetic nephropathy is associated with decreased circulating estra-diol levels and imbalance in the expression of renal estrogen receptors. Gend Med. 2005;2:227-237. (Pubitemid 43192759)
32. Zheng F, Plati AR, Potier M, et al. Resistance to glomerulo-sclerosis in B6 mice disappears after menopause. Am J Pathol. 2003;162:1339-1348. (Pubitemid 36350677)
33. Elliot SJ, Karl M, Berho M, et al. Estrogen defciency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol. 2003;162:1441-1448. (Pubitemid 36512826)
34. Dubey RK, Gillespie DG, Keller PJ, Imthurn B, Zacharia LC, Jackson EK. Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells. Hypertension. 2002;39(2 Pt 2):418-424. (Pubitemid 34165159)
35. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol. 2001;280:F365-F388.
36. Guccione M, Silbiger S, Lei J, Neugarten J. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol. 2002;282:F164-F169. (Pubitemid 34654211)
37. Kwan G, Neugarten J, Sherman M, et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int. 1996;50:1173-1179. (Pubitemid 26342807)
38. Neugarten J, Medve I, Lei J, Silbiger SR. Estradiol suppresses mesan-gial cell type I collagen synthesis via activation of the MAP kinase cascade. Am J Physiol. 1999;277(6 Pt 2):F875-F881. (Pubitemid 30046062)
39. Xiao S, Gillespie DG, Baylis C, Jackson EK, Dubey RK. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension. 2001;37(2 Part 2):645-650. (Pubitemid 32199043)
40. Potier KM, Schulman IH, Rivera A, Werner H, Fornoni A, Elliot SJ. Autocrine Activation of the Local Insulin-Like Growth Factor I System Is Up-Regulated by Estrogen Receptor (ER)-Independent Estrogen Actions and Accounts for Decreased ER Expression in Type 2 Diabetic Mesangial Cells. Endocrinology. 2005;146:889-900. (Pubitemid 40129847)
41. Stier CT Jr, Chander PN, Rosenfeld L, Powers CA. Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab. 2003;285: E232-E239. (Pubitemid 36736381)
42. Joles JA, van Goor H, Koomans HA. Estrogen induces glo-merulosclerosis in analbuminemic rats. Kidney Int. 1998;53:862-868. (Pubitemid 28155658)
43. Gades MD, Stern JS, van Goor H, Nguyen D, Johnson PR, Kaysen GA. Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int. 1998;53:130-135. (Pubitemid 28066912)
44. Jelinsky SA, Harris HA, Brown EL, et al. Global transcription profl-ing of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney. Endocrinology. 2003;144:701-710. (Pubitemid 36205244)
45. Sun J, Langer WJ, Devish K, Lane PH. Compensatory kidney growth in estrogen receptor-alpha null mice. Am J Physiol Renal Physiol. 2006;290:F319-F323. (Pubitemid 43724987)
46. Lovegrove AS, Sun J, Gould KA, Lubahn DB, Korach KS, Lane PH. Estrogen receptor alpha-mediated events promote sex-specifc diabetic glomerular hypertrophy. Am J Physiol Renal Physiol. 2004;287:F586-F591. (Pubitemid 39095975)
47. Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension. 2006;47:1019-1026. (Pubitemid 44289154)
48. Kummer S, Jeruschke S, Wegerich LV, et al. Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo. PLoS ONE. 2011;6:e27457.
49. Potier M, Karl M, Zheng F, Elliot SJ, Striker GE, Striker LJ. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol. 2002;160:1877-1885. (Pubitemid 34525667)
50. Esqueda ME, Craig T, Hinojosa-Laborde C. Effect of ovariectomy on renal estrogen receptor-alpha and estrogen receptor-beta in young salt-sensitive and-resistant rats. Hypertension. 2007;50:768-772. (Pubitemid 47442744)
51. Elliot SJ, Berho M, Korach K, et al. Gender-specifc effects of endogenous testosterone: female alpha-estrogen receptor-defcient C57Bl/6J mice develop glomerulosclerosis. Kidney Int. 2007;72:464-472. (Pubitemid 47237609)
52. Zhu Y, Bian Z, Lu P, et al. Abnormal vascular function and hypertension in mice defcient in estrogen receptor beta. Science. 2002;295:505-508. (Pubitemid 34101642)
53. Lindsey SH, Chappell MC. Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen. Gend Med. 2011;8:343-354.
54. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613. (Pubitemid 28502636)
55. Rossouw JE, Anderson GL, Prentice RL, et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefts of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333. (Pubitemid 34761611)
56. Dubey RK, Imthurn B, Barton M, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res. 2005;66:295-306. (Pubitemid 40471044)
57. Lombet JR, Adler SG, Anderson PS, Nast CC, Olsen DR, Glassock RJ. Sex vulnerability in the subtotal nephrectomy model of glomeru-losclerosis in the rat. J Lab Clin Med. 1989;114:66-74. (Pubitemid 19187547)
58. Reckelhoff JF, Baylis C. Glomerular metalloprotease activity is suppressed by androgens in the ageing kidney. J Am Soc Nephrol. 1993;3:1835-1838.
59. Reckelhoff JF, Yanes LL, Iliescu R, Fortepiani LA, Granger JP. Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol. 2005;289:F941-F948. (Pubitemid 41447048)
60. Baltatu O, Cayla C, Iliescu R, Andreev D, Jordan C, Bader M. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol. 2002;13:2681-2687. (Pubitemid 35216036)
61. Doublier S, Lupia E, Catanuto P, et al. Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomeru-losclerosis in female estrogen receptor knockout mice. Kidney Int. 2011;79:404-413.
62. Littleton-Kearney M, Hurn PD. Testosterone as a modulator of vascular behavior. Biol Res Nurs. 2004;5:276-285.
63. Rahman F, Christian HC. Non-classical actions of testosterone: an update. Trends Endocrinol Metab. 2007;18:371-378. (Pubitemid 350137764)
64. Laughlin GA, Barrett-Connor E, May S. Sex-specifc determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond). 2007;31:457-465.
65. Brinkworth GD, Noakes M, Moran LJ, Norman R, Clifton PM. Flow-mediated dilatation in overweight and obese women with poly-cystic ovary syndrome. BJOG. 2006;113:1308-1314. (Pubitemid 44581522)
66. Laughlin GA, Barrett-Connor E, May S. Sex-specifc association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study. Clin Endocrinol (Oxf). 2006;65:506-513. (Pubitemid 44414275)
67. Rizzo M, Rini GB, Carmina E. Androgen excess and cardiovascular risk. Minerva Endocrinol. 2007;32:67-71.
68. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT; Prevention of Renal and Vascular End Stage Disease Study Group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med. 2001;161:2000-2005.
69. Ahmed SB, Culleton BF, Tonelli M, et al.; Alberta Kidney Disease Network. Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int. 2008;74:370-376. (Pubitemid 352001252)
70. Agarwal M, Selvan V, Freedman BI, Liu Y, Wagenknecht LE. The relationship between albuminuria and hormone therapy in postmeno-pausal women. Am J Kidney Dis. 2005;45:1019-1025. (Pubitemid 40806514)
71. Baylis C. Nitric oxide defciency in chronic kidney disease. Gottschalk Lecture 2007. AJP Renal. 2008;294:F1-F9.
72. Nguyen Dinh Cat A, Touyz RM. Cell signaling of angioten-sin II on vascular tone: novel mechanisms. Curr Hypertens Rep. 2011;13:122-128.
73. Wolf G, Butzmann U, Wenzel UO. The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol. 2003;93:P3-P13. (Pubitemid 37499910)
74. Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol. 2011;11:180-186.
75. Erdely A, Greenfeld Z, Wagner L, Baylis C. Sexual dimorphism in the aging kidney; inverse relationship between injury and nitric oxide system. Kidney Int. 2003;63:1021-1026. (Pubitemid 36315580)
76. Hill C, Lateef AM, Engels K, Samsell L, Baylis C. Basal and stimulated nitric oxide in control of kidney function in the aging rat. Am J Physiol. 1997;272(6 Pt 2):R1747-R1753.
77. Lyons D, Roy S, Patel M, Benjamin N, Swift CG. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci. 1997;93:519-525. (Pubitemid 27517285)
78. Forte P, Kneale BJ, Milne E, et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension. 1998;32:730-734. (Pubitemid 28480552)
79. Neugarten J, Ding Q, Friedman A, Lei J, Silbiger S. Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol. 1997;8:1240-1246. (Pubitemid 27493628)
80. Holden DP, Cartwright JE, Nussey SS, Whitley GS. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation. 2003;108:1575-1580. (Pubitemid 37187783)
81. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004;286:R233-R249. (Pubitemid 38140366)
82. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313-340. (Pubitemid 36724373)
83. Verhagen AM, Attia DM, Koomans HA, Joles JA. Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: role of sex hormones. Am J Physiol Renal Physiol. 2000;279:F664-F670.
84. Vasudevan H, Nagareddy PR, McNeill JH. Gonadectomy prevents endothelial dysfunction in fructose-fed male rats, a factor contributing to the development of hypertension. Am J Physiol Heart Circ Physiol. 2006;291:H3058-H3064. (Pubitemid 44904108)
85. Attia DM, Goldschmeding R, Attia MA, Boer P, Koomans HA, Joles JA. Male gender increases sensitivity to renal injury in response to cholesterol loading. Am J Physiol Renal Physiol. 2003;284: F718-F726. (Pubitemid 36336978)
86. Baylis C. Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat Clin Pract Nephrol. 2009;5:384-396.
87. Mistry SK, Greenfeld Z, Morris SM, Baylis C. The 'intestinal-renal' arginine biosynthetic axis in the aging rat. Mech Ageing Dev. 2002;123:1159-1165. (Pubitemid 34603099)
88. Reckelhoff JF, Kellum JA, Blanchard EJ, Bacon EE, Wesley AJ, Kruckeberg WC. Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci. 1994;55:1895-1902. (Pubitemid 24347812)
89. Schulze F, Maas R, Freese R, Schwedhelm E, Silberhorn E, Böger RH. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects. Eur J Clin Invest. 2005;35:622-626. (Pubitemid 41406726)
90. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfeld JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994;24:471-476. (Pubitemid 24246550)
91. Bode-Böger SM, Muke J, Surdacki A, Brabant G, Böger RH, Frölich JC. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med. 2003;8:77-81. (Pubitemid 37168247)
92. Moens AL, Kass DA. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2006;26:2439-2444. (Pubitemid 44607463)
93. Smith C, Merchant M, Fekete A, et al. Splice variants of neuronal nitric oxide synthase are present in the rat kidney. Nephrol Dial Transplant. 2009;24:1422-1428.
94. Moningka NC, Sindler AL, Muller-Delp JM, Baylis C. Twelve weeks of treadmill exercise provides does not ameliorate the development of age-dependent kidney structural injury in the Fisher 344 male rat. J Physiol. 2011;589:6129-6138.
95. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, Leeuwenburgh C. New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci. 2010;123(Pt 15):2533-2542.
96. Vigneron A, Vousden KH. p53, ROS and senescence in the control of aging. Aging (Albany NY). 2010;2:471-474.
97. Yang H, Fogo AB. Cell senescence in the aging kidney. J Am Soc Nephrol. 2010;21:1436-1439.
98. de Cavanagh EM, Inserra F, Ferder L. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria? Cardiovasc Res. 2011;89:31-40.
99. Belmin J, Lévy BI, Michel JB. Changes in the renin-angiotensin- aldosterone axis in later life. Drugs Aging. 1994;5:391-400. (Pubitemid 2157457)
100. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009;119:524-530.
101. Diz DI. Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension. 2008;52:37-43.
102. Schulman IH, Zhou MS, Treuer AV, Chadipiralla K, Hare JM, Raij L. Altered renal expression of angiotensin II receptors, renin receptor, and ACE-2 precede the development of renal fbrosis in aging rats. Am J Nephrol. 2010;32:249-261.
103. Baylis C. Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically cath-eterized rat. Am J Kidney Dis. 1993;22:842-850. (Pubitemid 23353617)
104. Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB. Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int. 2000;58:2425-2436.
105. Komukai K, Mochizuki S, Yoshimura M. Gender and the renin-angiotensin- aldosterone system. Fundam Clin Pharmacol. 2010;24:687-698.
106. Sullivan JC. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1220-R1226. (Pubitemid 351490641)
107. Miller JA, Cherney DZ, Duncan JA, et al. Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol. 2006;17:2554-2560. (Pubitemid 44300971)